Enanta Pharmaceuticals shares owned by Millennium Management
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Millennium Management
from 13F filings
Historical chart of Millennium Management investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Millennium Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enanta Pharmaceuticals by Millennium Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $14M | 1.2M | 11.97 |
| 2025-06-30 | $11M | 1.5M | 7.56 |
| 2025-03-31 | $7.4M | 1.3M | 5.52 |
| 2024-12-31 | $5.2M | 897k | 5.75 |
| 2024-09-30 | $7.6M | 731k | 10.36 |
| 2024-06-30 | $8.9M | 683k | 12.97 |
| 2024-03-31 | $12M | 706k | 17.46 |
| 2023-12-31 | $7.2M | 765k | 9.41 |
| 2023-09-30 | $11M | 1.0M | 11.17 |
| 2023-06-30 | $5.0M | 234k | 21.40 |
| 2023-03-31 | $5.7M | 141k | 40.44 |
| 2022-12-31 | $2.6M | 56k | 46.52 |
| 2022-06-30 | $1.1M | 23k | 47.26 |
| 2022-03-31 | $5.4M | 76k | 71.18 |
| 2021-09-30 | $881k | 16k | 56.84 |
| 2021-06-30 | $6.2M | 141k | 44.01 |
| 2021-03-31 | $1.2M | 24k | 49.32 |
| 2020-12-31 | $7.4M | 177k | 42.10 |
| 2020-09-30 | $5.8M | 126k | 45.78 |
| 2020-06-30 | $1.9M | 37k | 50.21 |
| 2020-03-31 | $4.1M | 80k | 51.43 |
| 2019-12-31 | $2.3M | 37k | 61.79 |
| 2019-09-30 | $337k | 5.6k | 59.95 |
| 2019-06-30 | $5.5M | 65k | 84.37 |
| 2019-03-31 | $15M | 156k | 95.52 |
| 2018-12-31 | $1.5M | 21k | 70.82 |
| 2018-06-30 | $492k | 4.2k | 115.87 |
| 2018-03-31 | $7.3M | 90k | 80.90 |
| 2017-12-31 | $13M | 221k | 58.68 |
| 2017-06-30 | $18M | 487k | 35.98 |
| 2017-03-31 | $14M | 441k | 30.80 |
| 2016-12-31 | $3.2M | 95k | 33.50 |
| 2016-09-30 | $4.3M | 162k | 26.61 |
| 2016-06-30 | $937k | 43k | 22.04 |
| 2015-03-31 | $8.2M | 267k | 30.62 |
| 2014-12-31 | $509k | 10k | 50.90 |
| 2014-09-30 | $2.2M | 57k | 39.57 |
| 2014-06-30 | $233k | 5.4k | 43.03 |
| 2013-12-31 | $2.9M | 108k | 27.28 |